Cargando…
In Silico Approach for the Definition of radiomiRNomic Signatures for Breast Cancer Differential Diagnosis
Personalized medicine relies on the integration and consideration of specific characteristics of the patient, such as tumor phenotypic and genotypic profiling. Background: Radiogenomics aim to integrate phenotypes from tumor imaging data with genomic data to discover genetic mechanisms underlying tu...
Autores principales: | Gallivanone, Francesca, Cava, Claudia, Corsi, Fabio, Bertoli, Gloria, Castiglioni, Isabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929037/ https://www.ncbi.nlm.nih.gov/pubmed/31756987 http://dx.doi.org/10.3390/ijms20235825 |
Ejemplares similares
-
In Silico Discovery of Candidate Drugs against Covid-19
por: Cava, Claudia, et al.
Publicado: (2020) -
In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition
por: Cava, Claudia, et al.
Publicado: (2018) -
MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
por: Bertoli, Gloria, et al.
Publicado: (2016) -
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
por: Bertoli, Gloria, et al.
Publicado: (2015) -
Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
por: Bertoli, Gloria, et al.
Publicado: (2021)